{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:54:45Z","timestamp":1793717685469,"version":"4.6.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T00:00:00Z","timestamp":1514851200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s12035-017-0831-9","type":"journal-article","created":{"date-parts":[[2018,1,2]],"date-time":"2018-01-02T02:33:34Z","timestamp":1514860414000},"page":"6307-6318","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":73,"title":["Time Is Motor Neuron: Therapeutic Window and Its Correlation with Pathogenetic Mechanisms in Spinal Muscular Atrophy"],"prefix":"10.1007","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5393-5462","authenticated-orcid":false,"given":"Alessandra","family":"Govoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delia","family":"Gagliardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo P.","family":"Comi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,2]]},"reference":[{"issue":"6","key":"831_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nrneurol.2015.77","volume":"11","author":"I Faravelli","year":"2015","unstructured":"Faravelli I, Nizzardo M, Comi GP, Corti S (2015) Spinal muscular atrophy\u2014recent therapeutic advances for an old challenge. Nat Rev Neurol 11(6):351\u2013359. https:\/\/doi.org\/10.1038\/nrneurol.2015.77","journal-title":"Nat Rev Neurol"},{"key":"831_CR2","unstructured":"Sumner C, Paushkin S, Ko CP. Spinal muscular atrophy disease mechanisms and therapy. 1st Edition ISBN: 9780128036853 Academic Press 4th November 2016, Spinal Muscular Atrophy: 125 Years Later and on the Verge of a Cure M. Oskoui1, B.T. Darras2, D.C. De Vivo3 cap 1, 3\u201317"},{"issue":"6","key":"831_CR3","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.neuron.2005.12.001","volume":"48","author":"UR Monani","year":"2005","unstructured":"Monani UR (2005) Spinal muscular atrophy: a deficiency in a ubiquitous protein; a motor neuron-specific disease. Neuron 48(6):885\u2013896. Review. https:\/\/doi.org\/10.1016\/j.neuron.2005.12.001","journal-title":"Neuron"},{"issue":"6","key":"831_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/jmg.15.6.409","volume":"15","author":"J Pearn","year":"1978","unstructured":"Pearn J (1978) Incidence, prevalence, and gene frequency studies of chronic childhood spinal muscular atrophy. J Med Genet 15(6):409\u2013413. https:\/\/doi.org\/10.1136\/jmg.15.6.409","journal-title":"J Med Genet"},{"issue":"2","key":"831_CR5","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1055\/s-2001-15264","volume":"21","author":"K Talbot","year":"2001","unstructured":"Talbot K, Davies KE (2001) Spinal muscular atrophy. Semin Neurol 21(2):189\u2013197. https:\/\/doi.org\/10.1055\/s-2001-15264","journal-title":"Semin Neurol"},{"issue":"7","key":"831_CR6","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1093\/hmg\/8.7.1177","volume":"8","author":"UR Monani","year":"1999","unstructured":"Monani UR, Lorson CL, Parsons DW, Prior TW, Androphy EJ, Burghes AH, McPherson JD (1999) A single nucleotide difference that alters splicing patterns distinguishes the SMA gene SMN1 from the copy gene SMN2. Hum Mol Genet 8(7):1177\u20131183. https:\/\/doi.org\/10.1093\/hmg\/8.7.1177","journal-title":"Hum Mol Genet"},{"issue":"3","key":"831_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","volume":"15","author":"B Wirth","year":"2000","unstructured":"Wirth B (2000) An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat 15(3):228\u2013237. https:\/\/doi.org\/10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","journal-title":"Hum Mutat"},{"issue":"4","key":"831_CR8","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/ajmg.10425","volume":"110","author":"S Ogino","year":"2002","unstructured":"Ogino S, Leonard DG, Rennert H, Ewens WJ, Wilson RB (2002) Genetic risk assessment in carrier testing for spinal muscular atrophy. Am J Med Genet 110(4):301\u2013307. https:\/\/doi.org\/10.1002\/ajmg.10425","journal-title":"Am J Med Genet"},{"issue":"3","key":"831_CR9","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0959-437X(02)00301-5","volume":"12","author":"T Frugier","year":"2002","unstructured":"Frugier T, Nicole S, Cifuentes-Diaz C, Melki J (2002) The molecular bases of spinal muscular atrophy. Curr Opin Genet Dev 12(3):294\u2013298. https:\/\/doi.org\/10.1016\/S0959-437X(02)00301-5","journal-title":"Curr Opin Genet Dev"},{"issue":"2","key":"831_CR10","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.nmd.2012.09.006","volume":"23","author":"RS Finkel","year":"2013","unstructured":"Finkel RS (2013) Electrophysiological and motor function scale association in a pre-symptomatic infant with spinal muscular atrophy type I. Neuromuscul Disord 23(2):112\u2013115. https:\/\/doi.org\/10.1016\/j.nmd.2012.09.006","journal-title":"Neuromuscul Disord"},{"key":"831_CR11","doi-asserted-by":"crossref","unstructured":"Sumner C, Paushkin S, Ko CP. Spinal muscular atrophy disease mechanisms and therapy. 1st Edition ISBN: 9780128036853 Academic Press 4th November 2016, Transcriptional and Splicing Regulation of Spinal Muscular Atrophy Genes N.N. Singh, M.D. Howell, R.N. Singh cap 5, 75\u201397","DOI":"10.1016\/B978-0-12-803685-3.00005-7"},{"key":"831_CR12","doi-asserted-by":"publisher","unstructured":"Kolb SJ, Coffey CS, Yankey JW, Krosschell K, Arnold WD, Rutkove SB, Swoboda KJ, Reyna SP, Sakonju A, Darras BT, Shell R, Kuntz N, Castro D, Parsons J, Connolly AM, Chiriboga CA, McDonald C, Burnette WB, Werner K, Thangarajh M, Shieh PB, Finanger E, Cudkowicz ME, McGovern MM, McNeil DE, Finkel R, Iannaccone ST, Kaye E, Kingsley A, Renusch SR, McGovern VL, Wang X, Zaworski PG, Prior TW, Burghes AHM, Bartlett A, Kissel JT, NeuroNEXT Clinical Trial Network on behalf of the NN101 SMA Biomarker Investigators (2017) Natural history of infantile-onset spinal muscular atrophy. Ann Neurol. https:\/\/doi.org\/10.1002\/ana.25101","DOI":"10.1002\/ana.25101"},{"issue":"5","key":"831_CR13","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1002\/ana.20473","volume":"57","author":"KJ Swoboda","year":"2005","unstructured":"Swoboda KJ, Prior TW, Scott CB, NcNaught TP, Wride MC, Reyna SP (2005) Natural history of denervation in SMA: relation to age, SMN2 copy number, and function. Ann Neurol 57(5):704\u2013712. https:\/\/doi.org\/10.1002\/ana.20473","journal-title":"Ann Neurol"},{"issue":"Pt. 7","key":"831_CR14","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/brain\/awf155","volume":"125","author":"C Soler-Botija","year":"2002","unstructured":"Soler-Botija C, Ferrer I, Gich I, Baiget M, Tizzano EF (2002) Neuronal death is enhanced and begins during foetal development in type I spinal muscular atrophy spinal cord. Brain 125(Pt. 7):1624\u20131634. https:\/\/doi.org\/10.1093\/brain\/awf155","journal-title":"Brain"},{"issue":"5","key":"831_CR15","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1093\/jnen\/59.5.398","volume":"59","author":"G Simic","year":"2000","unstructured":"Simic G, Seso-Simic D, Lucassen PJ, Islam A, Krsnik Z, Cviko A, Jelasic D, Barisic N et al (2000) Ultrastructural analysis and TUNEL demonstrate motor neuron apoptosis in Werdnig-Hoffmann disease. J Neuropathol Exp Neurol 59(5):398\u2013407. https:\/\/doi.org\/10.1093\/jnen\/59.5.398","journal-title":"J Neuropathol Exp Neurol"},{"key":"831_CR16","unstructured":"Sumner C, Paushkin S, Ko CP. Spinal muscular atrophy disease mechanisms and therapy. 1st Edition ISBN: 9780128036853 Academic Press 4th November 2016, Developmental Aspects and Pathological Findings in Spinal Muscular Atrophy M.J. P\u00e9rez-Garc\u00eda1, L. Kong2, C.J. Sumner2, E.F. Tizzano1,3 cap 2, 21\u201342"},{"issue":"6","key":"831_CR17","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1001\/archneurol.2010.373","volume":"68","author":"P Kaufmann","year":"2011","unstructured":"Kaufmann P, McDermott MP, Darras BT, Finkel R, Kang P, Oskoui M, Constantinescu A, Sproule DM et al (2011) Observational study of spinal muscular atrophy type 2 and 3: functional outcomes over 1 year. Arch Neurol 68(6):779\u2013786. https:\/\/doi.org\/10.1001\/archneurol.2010.373","journal-title":"Arch Neurol"},{"key":"831_CR18","doi-asserted-by":"publisher","unstructured":"Hao le T, Duy PQ, Jontes JD, Wolman M, Granato M, Beattie CE (2013) Temporal requirement for SMN in motoneuron development. Hum Mol Genet 22(13):2612\u20132625. https:\/\/doi.org\/10.1093\/hmg\/ddt110","DOI":"10.1093\/hmg\/ddt110"},{"issue":"3","key":"831_CR19","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1093\/hmg\/ddp506","volume":"19","author":"LM Murray","year":"2010","unstructured":"Murray LM, Lee S, B\u00e4umer D, Parson SH, Talbot K, Gillingwater TH (2010) Pre-symptomatic development of lower motor neuron connectivity in a mouse model of severe spinal muscular atrophy. Hum Mol Genet 19(3):420\u2013433. https:\/\/doi.org\/10.1093\/hmg\/ddp506","journal-title":"Hum Mol Genet"},{"issue":"18","key":"831_CR20","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1093\/hmg\/ddn189","volume":"17","author":"VL McGovern","year":"2008","unstructured":"McGovern VL, Gavrilina TO, Beattie CE, Burghes AH (2008) Embryonic motor axon development in the severe SMA mouse. Hum Mol Genet 17(18):2900\u20132909. https:\/\/doi.org\/10.1093\/hmg\/ddn189","journal-title":"Hum Mol Genet"},{"issue":"18","key":"831_CR21","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1093\/hmg\/ddr275","volume":"20","author":"TT Le","year":"2011","unstructured":"Le TT, McGovern VL, Alwine IE, Wang X, Massoni-Laporte A, Rich MM, Burghes AH (2011) Temporal requirement for high SMN expression in SMA mice. Hum Mol Genet 20(18):3578\u20133591. https:\/\/doi.org\/10.1093\/hmg\/ddr275","journal-title":"Hum Mol Genet"},{"issue":"8","key":"831_CR22","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1172\/JCI57291","volume":"121","author":"CM Lutz","year":"2011","unstructured":"Lutz CM, Kariya S, Patruni S, Osborne MA, Liu D, Henderson CE, Li DK, Pellizzoni L et al (2011) Postsymptomatic restoration of SMN rescues the disease phenotype in a mouse model of severe spinal muscular atrophy. J Clin Invest 121(8):3029\u20133041. https:\/\/doi.org\/10.1172\/JCI57291","journal-title":"J Clin Invest"},{"issue":"6","key":"831_CR23","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1038\/mt.2011.72","volume":"19","author":"SJ Gray","year":"2011","unstructured":"Gray SJ, Matagne V, Bachaboina L, Yadav S, Ojeda SR, Samulski RJ (2011) Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates. Mol Ther 19(6):1058\u20131069. https:\/\/doi.org\/10.1038\/mt.2011.72","journal-title":"Mol Ther"},{"issue":"16","key":"831_CR24","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1093\/hmg\/ddn156","volume":"17","author":"S Kariya","year":"2008","unstructured":"Kariya S, Park GH, Maeno-Hikichi Y, Leykekhman O, Lutz C, Arkovitz MS, Landmesser LT, Monani UR (2008) Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum Mol Genet 17(16):2552\u20132569. https:\/\/doi.org\/10.1093\/hmg\/ddn156","journal-title":"Hum Mol Genet"},{"issue":"43","key":"831_CR25","doi-asserted-by":"publisher","first-page":"E5863","DOI":"10.1073\/pnas.1509758112","volume":"112","author":"LP Bogdanik","year":"2015","unstructured":"Bogdanik LP, Osborne MA, Davis C, Martin WP, Austin A, Rigo F, Bennett CF, Lutz CM (2015) Systemic, postsymptomatic antisense oligonucleotide rescues motor unit maturation delay in a new mouse model for type II\/III spinal muscular atrophy. Proc Natl Acad Sci U S A 112(43):E5863\u2013E5872. https:\/\/doi.org\/10.1073\/pnas.1509758112","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"22","key":"831_CR26","doi-asserted-by":"publisher","first-page":"6265","DOI":"10.1093\/hmg\/ddv329","volume":"24","author":"H Zhou","year":"2015","unstructured":"Zhou H, Meng J, Marrosu E, Janghra N, Morgan J, Muntoni F (2015) Repeated low doses of morpholino antisense oligomer: an intermediate mouse model of spinal muscular atrophy to explore the window of therapeutic response. Hum Mol Genet 24(22):6265\u20136277. https:\/\/doi.org\/10.1093\/hmg\/ddv329","journal-title":"Hum Mol Genet"},{"issue":"5","key":"831_CR27","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1093\/hmg\/ddv629","volume":"25","author":"Z Feng","year":"2016","unstructured":"Feng Z, Ling KK, Zhao X, Zhou C, Karp G, Welch EM, Naryshkin N, Ratni H et al (2016) Pharmacologically induced mouse model of adult spinal muscular atrophy to evaluate effectiveness of therapeutics after disease onset. Hum Mol Genet 25(5):964\u2013975. https:\/\/doi.org\/10.1093\/hmg\/ddv629","journal-title":"Hum Mol Genet"},{"issue":"1","key":"831_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/nbt.1515","volume":"27","author":"KD Foust","year":"2009","unstructured":"Foust KD, Nurre E, Montgomery CL, Hernandez A, Chan CM, Kaspar BK (2009) Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nat Biotechnol 27(1):59\u201365. https:\/\/doi.org\/10.1038\/nbt.1515","journal-title":"Nat Biotechnol"},{"issue":"3","key":"831_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/nbt.1610","volume":"28","author":"KD Foust","year":"2010","unstructured":"Foust KD, Wang X, McGovern VL, Braun L, Bevan AK, Haidet AM, Le TT, Morales PR et al (2010) Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN. Nat Biotechnol 28(3):271\u2013274. https:\/\/doi.org\/10.1038\/nbt.1610","journal-title":"Nat Biotechnol"},{"issue":"7","key":"831_CR30","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1089\/hum.2014.011","volume":"25","author":"MA Passini","year":"2014","unstructured":"Passini MA, Bu J, Richards AM, Treleaven CM, Sullivan JA, O\u2019Riordan CR, Scaria A, Kells AP et al (2014) Translational fidelity of intrathecal delivery of self-complementary AAV9-survival motor neuron 1 for spinal muscular atrophy. Hum Gene Ther 25(7):619\u2013630. https:\/\/doi.org\/10.1089\/hum.2014.011","journal-title":"Hum Gene Ther"},{"issue":"11","key":"831_CR31","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1038\/mt.2011.157","volume":"19","author":"AK Bevan","year":"2011","unstructured":"Bevan AK, Duque S, Foust KD, Morales PR, Braun L, Schmelzer L, Chan CM, McCrate M et al (2011) Systemic gene delivery in large species for targeting spinal cord, brain, and peripheral tissues for pediatric disorders. Mol Ther 19(11):1971\u20131980. https:\/\/doi.org\/10.1038\/mt.2011.157","journal-title":"Mol Ther"},{"key":"831_CR32","doi-asserted-by":"publisher","unstructured":"Gray SJ, Nagabhushan Kalburgi S, McCown TJ, Samulski RJ (2013) Global CNS gene delivery and evasion of anti-AAV-neutralizing antibodies by intrathecal AAV administration in non-human primates. Gene Ther 20(4):450\u2013459. Erratum in: Gene Ther 2013 Apr;20(4):465. https:\/\/doi.org\/10.1038\/gt.2012.101","DOI":"10.1038\/gt.2012.101"},{"issue":"4","key":"831_CR33","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1089\/hum.2011.200","volume":"23","author":"L Samaranch","year":"2012","unstructured":"Samaranch L, Salegio EA, San Sebastian W, Kells AP, Foust KD, Bringas JR, Lamarre C, Forsayeth J et al (2012) Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates. Hum Gene Ther 23(4):382\u2013389. https:\/\/doi.org\/10.1089\/hum.2011.200","journal-title":"Hum Gene Ther"},{"issue":"5","key":"831_CR34","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1089\/hum.2013.005","volume":"24","author":"L Samaranch","year":"2013","unstructured":"Samaranch L, Salegio EA, San Sebastian W, Kells AP, Bringas JR, Forsayeth J, Bankiewicz KS (2013) Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates. Hum Gene Ther 24(5):526\u2013532. https:\/\/doi.org\/10.1089\/hum.2013.005","journal-title":"Hum Gene Ther"},{"issue":"3","key":"831_CR35","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/mt.2014.210","volume":"23","author":"K Meyer","year":"2015","unstructured":"Meyer K, Ferraiuolo L, Schmelzer L, Braun L, McGovern V, Likhite S, Michels O, Govoni A et al (2015) Improving single injection CSF delivery of AAV9-mediated gene therapy for SMA\u2014a dose response study in mice and nonhuman primates. Mol Ther 23(3):477\u2013487. https:\/\/doi.org\/10.1038\/mt.2014.210","journal-title":"Mol Ther"},{"issue":"8","key":"831_CR36","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/gt.2011.130","volume":"19","author":"T Federici","year":"2012","unstructured":"Federici T, Taub JS, Baum GR, Gray SJ, Grieger JC, Matthews KA, Handy CR, Passini MA et al (2012) Robust spinal motor neuron transduction following intrathecal delivery of AAV9 in pigs. Gene Ther 19(8):852\u2013859. https:\/\/doi.org\/10.1038\/gt.2011.130","journal-title":"Gene Ther"},{"issue":"3","key":"831_CR37","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1002\/ana.24332","volume":"77","author":"SI Duque","year":"2015","unstructured":"Duque SI, Arnold WD, Odermatt P, Li X, Porensky PN, Schmelzer L, Meyer K, Kolb SJ et al (2015) A large animal model of spinal muscular atrophy and correction of phenotype. Ann Neurol 77(3):399\u2013414. https:\/\/doi.org\/10.1002\/ana.24332","journal-title":"Ann Neurol"},{"issue":"10","key":"831_CR38","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","volume":"86","author":"CA Chiriboga","year":"2016","unstructured":"Chiriboga CA, Swoboda KJ, Darras BT, Iannaccone ST, Montes J, De Vivo DC, Norris DA, Bennett CF et al (2016) Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy. Neurology 86(10):890\u2013897. https:\/\/doi.org\/10.1212\/WNL.0000000000002445","journal-title":"Neurology"},{"issue":"10063","key":"831_CR39","doi-asserted-by":"publisher","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","volume":"388","author":"RS Finkel","year":"2016","unstructured":"Finkel RS, Chiriboga CA, Vajsar J, Day JW, Montes J, De Vivo DC, Yamashita M, Rigo F et al (2016) Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study. Lancet 388(10063):3017\u20133026. https:\/\/doi.org\/10.1016\/S0140-6736(16)31408-8","journal-title":"Lancet"},{"issue":"18","key":"831_CR40","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT, Connolly AM, Kuntz NL, Kirschner J, Chiriboga CA, Saito K et al (2017) Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med 377(18):1723\u20131173. https:\/\/doi.org\/10.1056\/NEJMoa1702752","journal-title":"N Engl J Med"},{"issue":"18","key":"831_CR41","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","volume":"377","author":"JR Mendell","year":"2017","unstructured":"Mendell JR, Al-Zaidy S, Shell R, Arnold WD, Rodino-Klapac LR, Prior TW, Lowes L, Alfano L et al (2017) Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med 377(18):1713\u20131722. https:\/\/doi.org\/10.1056\/NEJMoa1706198","journal-title":"N Engl J Med"},{"issue":"1","key":"831_CR42","first-page":"100","volume":"13","author":"W Sulaiman","year":"2013","unstructured":"Sulaiman W, Gordon T (2013) Neurobiology of peripheral nerve injury, regeneration, and functional recovery: from bench top research to bedside application. Ochsner J 13(1):100\u2013108","journal-title":"Ochsner J"},{"key":"831_CR43","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.arr.2015.12.004","volume":"26","author":"C Domingues-Faria","year":"2016","unstructured":"Domingues-Faria C, Vasson MP, Goncalves-Mendes N, Boirie Y, Walrand S (2016) Skeletal muscle regeneration and impact of aging and nutrition. Ageing Res Rev 26:22\u201336. https:\/\/doi.org\/10.1016\/j.arr.2015.12.004","journal-title":"Ageing Res Rev"},{"issue":"11","key":"831_CR44","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1038\/nrn3821","volume":"15","author":"H Darabid","year":"2014","unstructured":"Darabid H, Perez-Gonzalez AP, Robitaille R (2014) Neuromuscular synaptogenesis: coordinating partners with multiple functions. Nat Rev Neurosci 15(11):703\u2013718. https:\/\/doi.org\/10.1038\/nrn3821","journal-title":"Nat Rev Neurosci"},{"issue":"7","key":"831_CR45","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S1474-4422(17)30085-6","volume":"16","author":"E Bertini","year":"2017","unstructured":"Bertini E, Dessaud E, Mercuri E, Muntoni F, Kirschner J, Reid C, Lusakowska A, Comi GP et al (2017) Safety and efficacy of olesoxime in patients with type 2 or non-ambulatory type 3 spinal muscular atrophy: a randomised, double-blind, placebo-controlled phase 2 trial. Lancet Neurol 16(7):513\u2013522. https:\/\/doi.org\/10.1016\/S1474-4422(17)30085-6","journal-title":"Lancet Neurol"},{"key":"831_CR46","doi-asserted-by":"crossref","unstructured":"Niranjan V, Bach JR (1998) Noninvasive management of pediatric neuromuscular ventilatory failure. Crit Care Med 26(12):2061\u20132065","DOI":"10.1097\/00003246-199812000-00042"},{"key":"831_CR47","doi-asserted-by":"crossref","unstructured":"Bach JR, Saltstein K, Sinquee D, Weaver B, Komaroff E (2007) Long-term survival in Werdnig-Hoffmann disease. Am J Phys Med Rehabil 86(5):339\u2013345 quiz 346\u2013348, 379","DOI":"10.1097\/PHM.0b013e31804a8505"},{"issue":"9","key":"831_CR48","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1212\/WNL.0000000000000741","volume":"83","author":"RS Finkel","year":"2014","unstructured":"Finkel RS, McDermott MP, Kaufmann P, Darras BT, Chung WK, Sproule DM, Kang PB, Foley AR et al (2014) Observational study of spinal muscular atrophy type I and implications for clinical trials. Neurology 83(9):810\u2013817. https:\/\/doi.org\/10.1212\/WNL.0000000000000741","journal-title":"Neurology"},{"issue":"3","key":"831_CR49","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/ana.23995","volume":"74","author":"WD Arnold","year":"2013","unstructured":"Arnold WD, Burghes AH (2013) Spinal muscular atrophy: development and implementation of potential treatments. Ann Neurol 74(3):348\u2013362. https:\/\/doi.org\/10.1002\/ana.23995","journal-title":"Ann Neurol"},{"issue":"3","key":"831_CR50","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.nmd.2009.11.014","volume":"20","author":"AM Glanzman","year":"2010","unstructured":"Glanzman AM, Mazzone E, Main M, Pelliccioni M, Wood J, Swoboda KJ, Scott C, Pane M et al (2010) The Children\u2019s Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and reliability. Neuromuscul Disord 20(3):155\u2013161. https:\/\/doi.org\/10.1016\/j.nmd.2009.11.014","journal-title":"Neuromuscul Disord"},{"issue":"2","key":"831_CR51","doi-asserted-by":"publisher","first-page":"e1500078","DOI":"10.1126\/sciadv.1500078","volume":"1","author":"M Nizzardo","year":"2015","unstructured":"Nizzardo M, Simone C, Rizzo F, Salani S, Dametti S, Rinchetti P, Del Bo R, Foust K et al (2015) Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model. Science Ad 1(2):e1500078. https:\/\/doi.org\/10.1126\/sciadv.1500078","journal-title":"Science Ad"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-017-0831-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0831-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-017-0831-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T18:38:50Z","timestamp":1570559930000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-017-0831-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,2]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["831"],"URL":"https:\/\/doi.org\/10.1007\/s12035-017-0831-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,2]]}}}